Abstract

Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications

Author(s): Zur Eyal

Issue: Nov/Dec 2018 - Volume 22, Number 6

Page(s): 446-454

Download in electronic PDF format for $75
  • Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Page 1
  • Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Page 2
  • Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Page 3
  • Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Page 4
  • Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Page 5
  • Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Page 6
  • Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Page 7
  • Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Page 8
  • Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Page 9

Abstract

Radiotherapy and epidermal growth factor receptor inhibitors, as important representatives of current chemotherapy, are crucial and irreplaceable treatments of modern oncology. These two types of treatments frequently cause severe dose-dependent dermatologic adverse events that can negatively affect a patient’s quality of life and compliance and cause inappropriate dose reductions and even treatment brakes. This article aims to emphasize new scientific data, published in peer reviews, regarding new possibilities to manage these debilitating dermatological adverse events. Since part of the scientific findings is new, the responsibility to enable pharmacologic treatment is in the compounding pharmacist domain. The article also suggests new formulations to the new pharmacologic treatment.

Related Keywords

  • cancer medicine
  • medical oncology
  • radiotherapy
  • epidermal growth factor receptor inhibitors
  • EGFR
  • dermatologic adverse events
  • acneiform rash
  • paronychia
  • inflammation
  • mucositis
  • xerosis
  • pruritus
  • hair changes
  • inflammatory changes
  • fingernails
  • keratinocytes
  • formulation
  • heparinoid cream
  • heparinoid lotion
  • topical preparations
  • ivermectin cream
  • ivermectin lotion
  • 5-aminolevulinic acid hydrochloride cream
  • case reports
  • radiation dermatitis
  • propranolol hydrochloride
  • topical corticosteroids

Related Categories

  • CANCER AND AIDS
  • DERMATOLOGY
  • FORMULATIONS
  • CASE REPORTS
  • ADVERSE DRUG EVENTS
  • PREVENTIVE MEDICINE/WELLNESS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2018
Pg. 446-454
Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications
Author(s): Zur Eyal
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Jul/Aug 2003
Pg. 266-270
Sensitization Therapy for Warts
Author(s): Kuntz Rachael
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Jan/Feb 2021
Pg. 18-23
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol
Author(s): McKettrick Greg, Yoch Doug
Sep/Oct 2023
Pg. 382-385
Excipients and Adverse Events
Author(s): Allen Loyd V Jr
Jan/Feb 2025
Pg. 33-36
Compounded GLP-1 Drugs and Patient Adverse Events
Author(s): Alliance for Pharmacy Compounding
Nov/Dec 2022
Pg. 446-466
Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Author(s): Allen Loyd V Jr
Jul/Aug 2010
Pg. 328-331
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program
Author(s): Okeke Claudia C, Allen Loyd V Jr
Jan/Feb 2013
Pg. 74-85
View Sample
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
May/Jun 2003
Pg. 170-174
Five Compounds for Treating Diabetes-Related Conditions
Author(s): Meece Jerry
Nov/Dec 2003
Pg. 426-435
View Sample
Sore Nipples in Breastfeeding Mothers: Causes and Treatments
Author(s): Albright Lisa M
Nov/Dec 2003
Pg. 460-463
View Sample
Basics of Compounding for Dry-Skin Conditions
Author(s): Allen Loyd V Jr
Mar/Apr 2012
Pg. 117-124
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum
Author(s): Zur Eyal
Nov/Dec 2016
Pg. 510
Imatinib 40-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Jan/Feb 2022
Pg. 6-8
Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report
Author(s): Garcia-Segura Laura Corral, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez
Sep/Oct 2021
Pg. 396-400
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved
Author(s): Allen Loyd V Jr
Nov/Dec 2011
Pg. 464-469
Diaper Rash Relief: Common Sense Remedies and Treatments
Author(s): Wiliams Kacee D, Williams LaVonn
Mar/Apr 2002
Pg. 96-97
Dermatologic and Cosmetic Lines from Compounding Pharmacies in Brazil
Author(s): Fonseca Simonne C, Ferreira Anderson de O